Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: The number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recovery

Journal of Hematotherapy and Stem Cell Research

Volumn 5, Issue 6, 1996, Pages 663-670

  Faucher, C ^a   Le Corroller, A G ^b   Chabannon, C ^a   Viens, P ^a   Stoppa, A M ^a   Bouabdallah, R ^a   Camerlo, J ^a   Vey, N ^a   Gravis, G ^a   Gastaut, J A ^a   Novakovitch, G ^a   Mannoni, P ^a   Bardou, V J ^a   Moatti, J P ^b   Maraninchi, D ^a   Blaise, D ^a  

^a INSTITUT PAOLI CALMETTES   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER CHEMOTHERAPY; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HODGKIN DISEASE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SOLID TUMOR; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; ANTIGENS, CD34; BLOOD CELL COUNT; BLOOD PLATELETS; FEMALE; FILGRASTIM; GRANULOCYTES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS;

EID: 3042970752     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. To, L.B., Roberts, M.M., Haylock, D.N., et al. Comparison of hematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cells transplant, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant. 9:277, 1992.
2. Faucher, C., Le Corroller, A.G., Blaise, D., et al. Comparison of G-CSF primed peripheral blood progenitor cells and bone marrow auto transplantation: Clinical assessment and cost-effectiveness. Bone Marrow Transplant. 14:895, 1994.
3. Gianni, A.L., Siena, S., Bregni, M., et al. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 9:580, 1989.
4. Kessinger, A., Armitage, J.O., Smith, D.M., et al. High dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 74:1260, 1989.
5. Bensinger, W., Singer, J., Appelbaum, F., et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 81:3158, 1993.
6. Peters, P., Rosner, G., Ross, M., et al. Comparative effects of granulocyte-macrophage colony stimulating factor (GM-CSF) and granulocyte-colony stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high dose chemotherapy. Blood 81:1709, 1993.
7. Siena, S., Bregni, M., Brandon, M., et al. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high dose cyclophosphamide-treated patients: Enhancement by intravenous recombinant human granulocyte-colony stimulating factor. Blood 74:1905, 1989.
8. To, L.B., Shepperd, K.M., Haylock, D.N., et al. Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp. Hematol. 18:442, 1990.
9. Sheridan, W.P., Begley, G.C., Juttner, C.A., et al. Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640, 1992.
10. Nademanee, A., Sniecinski, I., Schmidt, G., et al. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells. J. Clin. Oncol. 12:2176, 1994.
11. Chabannon, C., Le Corroller, A.G., Faucher, C., et al. Patient condition affects the collection of peripheral blood progenitors after priming with recombinant granulocyte colony-stimulating factor. J. Hematother. 4:171, 1995.
12. Gaspard, M.H., Maraninchi, D., Stoppa, A.M., et al. Intensive chemotherapy with high dose of BCNU, etoposide, cytosine arabinoside and melphalan (BEAM) followed by autologous BMT: Toxicity and antitumor activity in 26 patients with poor risk malignancies. Cancer Chemother. Pharmacol. 22:256, 1988.
13. Gisselbrecht, C., Devaux, Y., Lotz, J.P., et al. Autologous bone marrow transplantation (ABMT) after high dose cyclophosphamide, mitoxantrone, alkeran (CMA) in breast cancer. AACR, 82nd Annual Meeting, Houston, TX, May 19-21, 1991 (abstract 4674).
14. Benitah, E. Comparative study between maximal isolation (LAF) and minimal isolation (HEPA filtration) for autologous and allogeneic bone marrow transplantation. 1990 European Bone Marrow Transplantation (Nurses) Annual Meeting, May 6-9, 1990.
15. Faucher, C., Le Corroller, A.G., Chabannon, C., et al. G-CSF can be delayed after blood stem cells transplantation: A randomized study. Bone Marrow Transplant. 17:533, 1996.
16. ™: User's Guide, release 6.0, 1993.
17. Haas, R., Ehrhardt, R., Witt, B., et al. Autografting with peripheral blood stem cells mobilized by sequential interleukin-3/granulocyte-macrophage colony-stimulating factor following high-dose chemotherapy in non-Hodgkin's lymphoma. Bone Marrow Transplant. 12:643, 1993.
18. Andrews, R.G., Bridell, R.A., Knitter, G.H., et al. Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates. Blood 85:15, 1995.
19. Haylock, D.N., To, L.B., Dowse, T.L., et al. Ex-vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. Blood 80:1405, 1992.
20. Van der Wall, E., Richel, D.J., Holtkamp, M.J., et al. Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: Effect of graft size. Ann. Oncol. 5:795, 1994.
21. Siena, S., Bregni, M., Brandon, M., et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77:400, 1991.
22. Haas, R., Moos, M., Karcher, A., et al. Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma. J. Clin. Oncol. 12:1685, 1994.
23. Pettengel, R., Morgenstern, G.R., Woll, P.J., et al. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 82:3770, 1993.
24. Gianni, A.M. Where do we stand with respect to the use of peripheral blood progenitor cells? Ann. Oncol. 5:781, 1994.
25. Siena, S., Bregni, M., Di Nicola, M., et al. Durability of hematotopoiesis following autografting with peripheral blood hematopoietic progenitors. Ann. Oncol. 5:935, 1994.
26. Dercksen, MAV., Rodenhuis, S., Dirkson, M.K.A., et al. Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral blood stem cell transplantation. J. Clin. Oncol. 13:1922, 1995.
27. Reiffers, J., Faberes, C., Boiron, J.M., et al. Peripheral blood progenitor cell transplantation in 118 patients with hematological malignancies: Analysis of factors affecting the rate of engraftment. J. Hematother. 3:185, 1994.
28. Gisselbrecht, C., Prentice, H.G., Bacigalupo, A., et al. Placebo-controlled phase III trial of lenograstim in bone marrow transplantation. Lancet 343:696, 1994.
29. Nemunaitis, J., Rabinowe, S.N., Singer, J.W., et al. Recombinant granulocyte macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N. Engl. J. Med. 324:1773, 1991.
30. Bensinger, W.I., Weaver, C.H., Appelbaum, F.R., et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655, 1995.
31. Körbling, M., Przlepiorka, D., Huh, Y.O., et. al. Allogeneic blood stem cells tranplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood 85:1659, 1995.
32. Schmitz, N., Dreger, P., Suttorp, M., et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 85:1666, 1995.